Chemoinformaics analysis of Pseduosarsasapogenin-5
| Molecular Weight | 460.699 | nRot | 6 |
| Heavy Atom Molecular Weight | 412.315 | nRig | 24 |
| Exact Molecular Weight | 460.355 | nRing | 5 |
| Solubility: LogS | -5.52 | nHRing | 1 |
| Solubility: LogP | 5.397 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 83.6441 |
| nHD | 1 | BPOL | 53.3619 |
| QED | 0.496 |
| Synth | 4.958 |
| Natural Product Likeliness | 3.021 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.919 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.755 |
| MDCK | 0.0000418 |
| BBB | 0.422 |
| PPB | 0.971773 |
| VDSS | 1.875 |
| FU | 0.0172514 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.597 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.115 |
| CYP2c9-sub | 0.06 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.734 |
| CYP3a4-inh | 0.215 |
| CYP3a4-sub | 0.613 |
| CL | 17.987 |
| T12 | 0.025 |
| hERG | 0.021 |
| Ames | 0.042 |
| ROA | 0.763 |
| SkinSen | 0.197 |
| Carcinogencity | 0.117 |
| EI | 0.008 |
| Respiratory | 0.258 |
| NR-Aromatase | 0.582 |
| Antiviral | Yes |
| Prediction | 0.610391 |